Merck selling off lipids business unit

[Anonymous]

Merck working on selling off lipids franchise prior to outcomes study being released. It is a craps shoot right now and it has been decided that this is not our core focus and we are better selling it off and making a deal for a percentage of future sales. Announcement coming soon!!

 

[Anonymous]

It's plausible in light of what happened with Saphris, but I haven't heard of any plans. Stop trying to get us going. lets just enjoy a nice start to the new year.

 

[Anonymous]

Merck working on selling off lipids franchise prior to outcomes study being released. It is a craps shoot right now and it has been decided that this is not our core focus and we are better selling it off and making a deal for a percentage of future sales. Announcement coming soon!!

I daydream too. If this is for real, how do you know?

 

[Anonymous]

Merck working on selling off lipids franchise prior to outcomes study being released. It is a craps shoot right now and it has been decided that this is not our core focus and we are better selling it off and making a deal for a percentage of future sales. Announcement coming soon!!

Not true....

 

[Anonymous]

Huh???????
Keep diabetes and dump lipids?

Make no sense unless we get into weight loss, fitness, meter or other diabetes related products.

Hmmmmmmm.

 

[Anonymous]

Richard Simmons is going to be our spokesperson. We can sweat to the oldies, reminiscing of the good times.

 

[Anonymous]

Who do you think would buy it? Still very profitable.

 

[Anonymous]

Richard Simmons is going to be our spokesperson. We can sweat to the oldies, reminiscing of the good times.

Sounds good I can use it!

 

[Anonymous]

If we are going to unload this franchise it would be smart to ink the deal when there is money to be had. If we roll the dice and get unfavorable results with improve it trial we are done for without any deal to be had. That is why senior management is trying to finalize a deal soon. Stay tuned!

 

[Anonymous]

Just sell Liptruzet to one of these lame ass start-up companies who will pay mad money for it!

We all know this drug will NEVER meet sales goals or be a blockbuster, but someone out there will pay for the chance for what they THINK will be a f'n goldmine!!

 

[Anonymous]

Just sell Liptruzet to one of these lame start-up companies who will pay mad money for it!

We all know this drug will NEVER meet sales goals or be a blockbuster, but someone out there will pay for the chance for what they THINK will be a goldmine!!

 

[Anonymous]

Huh???????
Keep diabetes and dump lipids?

Make no sense unless we get into weight loss, fitness, meter or other diabetes related products.

Hmmmmmmm.

It makes sense if they plan to acquire a company with a lipids portfolio and dodge anti-trust. Remember how they dumped Aggrastat before they acquired Schering to avoid anti-trust with Integrilin?

 

[Anonymous]

When do you feel this divestiture will take place? I can definitely see this happening.

 

[Anonymous]

Just sell Liptruzet to one of these lame ass start-up companies who will pay mad money for it!

We all know this drug will NEVER meet sales goals or be a blockbuster, but someone out there will pay for the chance for what they THINK will be a f'n goldmine!!

Try selling it to Crealta....they just bought Krystexxa for 120MM...idiots.

 

[Anonymous]

This is a 50/50 shot. Pretty much reading between the lines of the NY Times article.

 

[Anonymous]

bye liptruzet...you were a bad bet and my sales goals were never met.